John Bencich

2020

In 2020, John Bencich earned a total compensation of $883.7K as Chief Executive Officer and Former Chief Financial Officer and Chief Operating Officer at OncoGenex Pharmaceuticals, a 55% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$199,610
Option Awards$263,208
Salary$420,914
Total$883,732

Bencich received $420.9K in salary, accounting for 48% of the total pay in 2020.

Bencich also received $199.6K in non-equity incentive plan and $263.2K in option awards.

Rankings

In 2020, John Bencich's compensation ranked 9,118th out of 13,090 executives tracked by ExecPay. In other words, Bencich earned more than 30.3% of executives.

ClassificationRankingPercentile
All
9,118
out of 13,090
30th
Division
Manufacturing
3,898
out of 5,618
31st
Major group
Chemicals And Allied Products
1,579
out of 2,251
30th
Industry group
Drugs
1,380
out of 1,951
29th
Industry
In Vitro and In Vivo Diagnostic Substances
39
out of 60
35th
Source: SEC filing on March 30, 2021.

Bencich's colleagues

We found two more compensation records of executives who worked with John Bencich at OncoGenex Pharmaceuticals in 2020.

2020

Richard Stewart

OncoGenex Pharmaceuticals

Chief Executive Officer

2020

Cindy Jacobs

OncoGenex Pharmaceuticals

Chief Medical Officer

News

You may also like